Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum

References

• Lopes AP, Mineiro MA, Costa F, et al. Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology. 2018;24(Suppl 1):1–21. doi:10.1016/j.pulmoe.2018.09.004
   PubMedGoogle Scholar
• Silva D, Oliveira MJ, Guimarães M, Lima R, Gomes S, Seixas S. Alpha-1-antitrypsin (SERPINA1) mutation spectrum: three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal. Respir Med. 2016;116:8–18. doi:10.1016/j.rmed.2016.05.002
   PubMed Web of Science ®Google Scholar
• Stein PE, Carrell RW. What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol. 1995;2(2):96–113. doi:10.1038/nsb0295-96
   Google Scholar
• Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Kohnlein T, Welte T. The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med. 2011;105(8):1129–1139. doi:10.1016/j.rmed.2011.02.002
   PubMed Web of Science ®Google Scholar
• ATS/ERS. American thoracic society/European respiratory society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818–900. doi:10.1164/rccm.168.7.818.
   Web of Science ®Google Scholar
• Greene CM, Marciniak SJ, Teckman J, et al. Alpha1-antitrypsin deficiency. Nat Rev Dis Primers. 2016;2(1):16051. doi:10.1038/nrdp.2016.51
   PubMed Web of Science ®Google Scholar
• WHO. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997;75(5):397–415.
   Web of Science ®Google Scholar
• Ghouse R, Chu A, Wang Y, Perlmutter DH. Mysteries of 1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease. Dis Model Mech. 2014;7(4):411–419. doi:10.1242/dmm.014092
   Web of Science ®Google Scholar
• Lomas DA, Hurst JR, Gooptu B. Update on alpha-1 antitrypsin deficiency: new therapies. J Hepatol. 2016;65(2):413–424. doi:10.1016/j.jhep.2016.03.010
   Web of Science ®Google Scholar
• de Serres FJ, Blanco I. Prevalence of alpha1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review. Ther Adv Respir Dis. 2012;6(5):277–295. doi:10.1177/1753465812457113
   PubMed Web of Science ®Google Scholar
• Blanco I, de Serres FJ, Carcaba V, Lara B, Fernandez-Bustillo E. Alpha-1 antitrypsin deficiency PI*Z and PI*S gene frequency distribution using on maps of the world by an inverse distance weighting (IDW) multivariate interpolation method. Hepat Mon. 2012;12(10HCC):e7434. doi:10.5812/hepatmon.7434
   Web of Science ®Google Scholar
• Giacopuzzi E, Laffranchi M, Berardelli R, et al. Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. Hum Mutat. 2018;39(9):1203–1213. doi:10.1002/humu.23562
   Web of Science ®Google Scholar
• Rodriguez-Frias F, Miravitlles M, Vidal R, Camos S, Jardi R. Rare alpha-1-antitrypsin variants: are they really so rare? Ther Adv Respir Dis. 2012;6(2):79–85. doi:10.1177/1753465811434320
   PubMed Web of Science ®Google Scholar
• Irving JA, Cabrita LD, Kaiserman D, Worrall MM, Whisstock JC. Evolution and classification of the serpin superfamily. In: Silverman GA, Lomas DA, editors. Molecular and Cellular Aspects of the Serpinopathies and Disorders in Serpin Activity. World Scientific Publishing;2007:1–33.chap 1.
   Google Scholar
• Seixas S. The human SERPIN repertoire and the evolution of 14q32.1 and 18q21.3 gene clusters. In: Geiger M, Furtmüller M, Wahlmüller F, editors. The Serpin Family Proteins with Multiple Functions in Health and Disease. Springer International Publishing; 2015:1–14.
   Google Scholar
• Long GL, Chandra T, Woo SL, Davie EW, Kurachi K. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry. 1984;23(21):4828–4837. doi:10.1021/bi00316a003
   Web of Science ®Google Scholar
• Bergin DA, Reeves EP, Meleady P, et al. Alpha-1 antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest. 2010;120(12):4236–4250. doi:10.1172/JCI41196
   PubMed Web of Science ®Google Scholar
• Gooptu B, Dickens JA, Lomas DA. The molecular and cellular pathology of alpha(1)-antitrypsin deficiency. Trends Mol Med. 2014;20(2):116–127. doi:10.1016/j.molmed.2013.10.007
   Web of Science ®Google Scholar
• Gooptu B, Ekeowa UI, Lomas DA. Mechanisms of emphysema in 1-antitrypsin deficiency: molecular and cellular insights. Eur Respir J. 2009;34(2):475–488. doi:10.1183/09031936.00096508
   Web of Science ®Google Scholar
• Irving JA, Pike RN, Lesk AM, Whisstock JC. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 2000;10(12):1845–1864. doi:10.1101/gr.GR-1478R
   PubMed Web of Science ®Google Scholar
• Bergin DA, Hurley K, McElvaney NG, Reeves EP. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp (Warsz). 2012;60(2):81–97. doi:10.1007/s00005-012-0162-5
   PubMed Web of Science ®Google Scholar
• Jonigk D, Al-Omari M, Maegel L, et al. Anti-inflammatory and immunomodulatory properties of alpha1-antitrypsin without inhibition of elastase. Proc Natl Acad Sci U S A. 2013;110(37):15007–15012. doi:10.1073/pnas.1309648110
   PubMed Web of Science ®Google Scholar
• Ferrarotti I, Thun GA, Zorzetto M, et al. Serum levels and genotype distribution of alpha1-antitrypsin in the general population. Thorax. 2012;67(8):669–674. doi:10.1136/thoraxjnl-2011-201321
   PubMed Web of Science ®Google Scholar
• Tonelli AR, Brantly ML. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies. Ther Adv Respir Dis. 2010;4(5):289–312. doi:10.1177/1753465810373911
   Google Scholar
• Marsden MD, Fournier RE. Organization and expression of the human serpin gene cluster at 14q32.1. Front Biosci. 2005;10(1–3):1768–1778. doi:10.2741/1660
   Google Scholar
• Laurell CB, Eriksson S. The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Copd. 2013;10(Suppl 1):3–8. doi:10.3109/15412555.2013.771956
   PubMedGoogle Scholar
• Laurell C-B, Eriksson S. The electrophoretic α;1-globulin pattern of serum in α;1-antitrypsin deficiency. Scand J Clin Lab Invest. 1963;15(2):132–140. doi:10.1080/00365516309051324
   Web of Science ®Google Scholar
• Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax. 2004;59(2):164–169. doi:10.1136/thorax.2003.006494
   PubMed Web of Science ®Google Scholar
• Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes Abridged Paperback Edition. Princeton University Press; 1994.
   Google Scholar
• Rachelefsky G, Hogarth DK. Issues in the diagnosis of alpha 1-antitrypsin deficiency. J Allergy Clin Immunol. 2008;121(4):833–838. doi:10.1016/j.jaci.2007.12.1183
   Web of Science ®Google Scholar
• den Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564–569. doi:10.1002/humu.22981
   PubMed Web of Science ®Google Scholar
• Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med. 1988;84(6A):13–31. doi:10.1016/0002-9343(88)90154-4
   PubMed Web of Science ®Google Scholar
• Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443. doi:10.1038/s41586-020-2308-7
   PubMed Web of Science ®Google Scholar
• Cox DW, Woo SL, Mansfield T. DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature. 1985;316(6023):79–81. doi:10.1038/316079a0
   Web of Science ®Google Scholar
• Faull SV, Elliston ELK, Gooptu B, et al. The structural basis for Z α 1-antitrypsin polymerization in the liver. Sci Adv. 2020;6(43):eabc1370. doi:10.1126/sciadv.abc1370
   Web of Science ®Google Scholar
• Yamasaki M, Sendall TJ, Pearce MC, Whisstock JC, Huntington JA. Molecular basis of alpha1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer. EMBO Rep. 2011;12(10):1011–1017. doi:10.1038/embor.2011.171
   PubMed Web of Science ®Google Scholar
• Patel D, Teckman JH. Alpha-1-antitrypsin deficiency liver disease. Clin Liver Dis. 2018;22(4):643–655. doi:10.1016/j.cld.2018.06.010
   PubMed Web of Science ®Google Scholar
• Mayhew D, Devos N, Lambert C, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018. doi:10.1136/thoraxjnl-2017-210408
   Web of Science ®Google Scholar
• Sinden NJ, Koura F, Stockley RA. The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote. BMC Pulm Med. 2014;14(1):132. doi:10.1186/1471-2466-14-132
   Web of Science ®Google Scholar
• Blanco I, de Serres FJ, Fernandez-Bustillo E, Lara B, Miravitlles M. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J. 2006;27(1):77–84. doi:10.1183/09031936.06.00062305
   PubMed Web of Science ®Google Scholar
• Lomas DA. The selective advantage of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2006;173(10):1072–1077. doi:10.1164/rccm.200511-1797PP
   PubMed Web of Science ®Google Scholar
• North TL, Ben-Shlomo Y, Cooper C, et al. A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height. J Med Genet. 2016;53(4):280–288. doi:10.1136/jmedgenet-2015-103342
   Web of Science ®Google Scholar
• Stephens JC, Reich DE, Goldstein DB, et al. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet. 1998;62(6):1507–1515. doi:10.1086/301867
   Web of Science ®Google Scholar
• Galvani AP, Slatkin M. Evaluating plague and smallpox as historical selective pressures for the CCR5-delta 32 HIV-resistance allele. Proc Natl Acad Sci U S A. 2003;100(25):15276–15279. doi:10.1073/pnas.2435085100
   Web of Science ®Google Scholar
• Sabeti PC, Walsh E, Schaffner SF, et al. The case for selection at CCR5-delta32. PLoS Biol. 2005;3(11):e378. doi:10.1371/journal.pbio.0030378
   Web of Science ®Google Scholar
• Novembre J, Han E. Human population structure and the adaptive response to pathogen-induced selection pressures. Philos Trans R Soc Lond B Biol Sci. 2012;367(1590):878–886. doi:10.1098/rstb.2011.0305
   PubMed Web of Science ®Google Scholar
• Novembre J, Galvani AP, Slatkin M. The geographic spread of the CCR5 delta32 HIV-resistance allele. PLoS Biol. 2005;3(11):e339. doi:10.1371/journal.pbio.0030339
   PubMed Web of Science ®Google Scholar
• Lace B, Sveger T, Krams A, Cernevska G, Krumina A. Age of SERPINA1 gene PI Z mutation: Swedish and Latvian population analysis. Ann Hum Genet. 2008;72(Pt3):300–304. doi:10.1111/j.1469-1809.2008.00431.x
   Web of Science ®Google Scholar
• Seixas S, Garcia O, Trovoada MJ, Santos MT, Amorim A, Rocha J. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum Genet. 2001;108(1):20–30. doi:10.1007/s004390000434
   Web of Science ®Google Scholar
• Veeramah KR, Novembre J. Demographic events and evolutionary forces shaping European genetic diversity. Cold Spring Harb Perspect Biol. 2014;6(9):a008516. doi:10.1101/cshperspect.a008516
   Web of Science ®Google Scholar
• Elliott PR, Stein PE, Bilton D, Carrell RW, Lomas DA. Structural explanation for the deficiency of S alpha 1-antitrypsin. Nat Struct Biol. 1996;3(11):910–911. doi:10.1038/nsb1196-910
   Google Scholar
• Teckman JH, Perlmutter DH. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem. 1996;271(22):13215–13220. doi:10.1074/jbc.271.22.13215
   PubMed Web of Science ®Google Scholar
• Laffranchi M, Berardelli R, Ronzoni R, Lomas DA, Fra A. Heteropolymerization of alpha-1-antitrypsin mutants in cell models mimicking heterozygosity. Hum Mol Genet. 2018;27(10):1785–1793. doi:10.1093/hmg/ddy090
   Web of Science ®Google Scholar
• Mahadeva R, Chang WS, Dafforn TR, et al. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest. 1999;103(7):999–1006. doi:10.1172/JCI4874
   PubMed Web of Science ®Google Scholar
• McElvaney GN, Sandhaus RA, Miravitlles M, et al. Clinical considerations in individuals with α1-antitrypsin PI*SZ genotype. Eur Respir J. 2020;55(6):1902410. doi:10.1183/13993003.02410-2019
   Web of Science ®Google Scholar
• Green CE, Vayalapra S, Hampson JA, Mukherjee D, Stockley RA, Turner AM. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD. Thorax. 2015;70(10):939–945. doi:10.1136/thoraxjnl-2015-206906
   PubMed Web of Science ®Google Scholar
• Choate R, Mannino DM, Holm KE, Sandhaus RA. Comparing patients with ZZ versus SZ alpha-1 antitrypsin deficiency: findings from AlphaNet’s disease management program. Chronic Obstr Pulm Dis. 2018;6(1):29–39. doi:10.15326/jcopdf.6.1.2018.0134
   Web of Science ®Google Scholar
• Piras B, Ferrarotti I, Lara B, et al. Clinical phenotypes of Italian and Spanish patients with alpha1-antitrypsin deficiency. Eur Respir J. 2013;42(1):54–64. doi:10.1183/09031936.00104712
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Forgetta V, Handa T, et al. The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes. Eur Respir J. 2020;56(6):2001441. doi:10.1183/13993003.01441-2020
   PubMed Web of Science ®Google Scholar
• Bornhorst JA, Greene DN, Ashwood ER, Grenache DG. Alpha1-antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest. 2013;143(4):1000–1008. doi:10.1378/chest.12-0564
   PubMed Web of Science ®Google Scholar
• Blanco I, Bueno P, Diego I, et al. Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide. Int J Chron Obstruct Pulmon Dis. 2017;12:1683–1694. doi:10.2147/COPD.S137852
   PubMed Web of Science ®Google Scholar
• Hutchison DC. Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. Respir Med. 1998;92(3):367–377. doi:10.1016/s0954-6111(98)90278-5
   PubMed Web of Science ®Google Scholar
• Spinola C, Bruges-Armas J, Pereira C, Brehm A, Spinola H. Alpha-1-antitrypsin deficiency in Madeira (Portugal): the highest prevalence in the world. Respir Med. 2009;103(10):1498–1502. doi:10.1016/j.rmed.2009.04.012
   PubMed Web of Science ®Google Scholar
• Fortes-Lima C, Verdu P. Anthropological genetics perspectives on the transatlantic slave trade. Hum Mol Genet. 2020. doi:10.1093/hmg/ddaa271
   Web of Science ®Google Scholar
• Tomas G, Seco L, Seixas S, Faustino P, Lavinha J, Rocha J. The peopling of Sao Tome (Gulf of Guinea): origins of slave settlers and admixture with the Portuguese. Hum Biol. 2002;74(3):397–411. doi:10.1353/hub.2002.0036
   PubMed Web of Science ®Google Scholar
• Kehdy FS, Gouveia MH, Machado M, et al. Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations. Proc Natl Acad Sci U S A. 2015;112(28):8696–8701. doi:10.1073/pnas.1504447112
   PubMed Web of Science ®Google Scholar
• Seyama K, Nukiwa T, Takabe K, Takahashi H, Miyake K, Kira S. Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J Biol Chem. 1991;266(19):12627–12632. doi:10.1016/S0021-9258(18)98945-3
   Web of Science ®Google Scholar
• Matsunaga E, Shiokawa S, Nakamura H, Maruyama T, Tsuda K, Fukumaki Y. Molecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, Mnichinan. Am J Hum Genet. 1990;46(3):602–612.
   Web of Science ®Google Scholar
• Curiel DT, Holmes MD, Okayama H, et al. Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton. J Biol Chem. 1989;264(23):13938–13945. doi:10.1016/S0021-9258(18)80090-4
   Web of Science ®Google Scholar
• Graham A, Kalsheker NA, Newton CR, Bamforth FJ, Powell SJ, Markham AF. Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256—-Val); PiMmalton (Phe51—-deletion) and PiI (Arg39—-Cys). Hum Genet. 1989;84(1):55–58. doi:10.1007/BF00210671
   Web of Science ®Google Scholar
• Faber JP, Poller W, Weidinger S, et al. Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele. Am J Hum Genet. 1994;55(6):1113–1121.
   Web of Science ®Google Scholar
• Hernandez-Perez JM, Ramos-Diaz R, Fumero-Garcia S, Perez JA. Molecular characterization of PI*Q0la palma, a new alpha-1-antitrypsin null allele that combines two defective genetic variants. Clin Genet. 2017;91(6):927–928. doi:10.1111/cge.12889
   Web of Science ®Google Scholar
• Seyama K, Nukiwa T, Souma S, Shimizu K, Kira S. Alpha 1-antitrypsin-deficient variant Siiyama (Ser53[TCC] to Phe53[TTC]) is prevalent in Japan. Status of alpha 1-antitrypsin deficiency in Japan. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2119–2126. doi:10.1164/ajrccm.152.6.8520784
   PubMed Web of Science ®Google Scholar
• Meira L, Boaventura R, Seixas S, Sucena M. Alpha-1 antitrypsin deficiency detection in a Portuguese population. COPD. 2018;1–6. doi:10.1080/15412555.2017.1414779
   Google Scholar
• Ferrarotti I. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet. 2005;42(3):282–287. doi:10.1136/jmg.2004.023903
   PubMed Web of Science ®Google Scholar
• Canva V, Piotte S, Aubert JP, et al. Heterozygous M3Mmalton alpha1-antitrypsin deficiency associated with end-stage liver disease: case report and review. Clin Chem. 2001;47(8):1490–1496. doi:10.1093/clinchem/47.8.1490
   PubMed Web of Science ®Google Scholar
• Joly P, Guillaud O, Hervieu V, Francina A, Mornex JF, Chapuis-Cellier C. Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states. Orphanet J Rare Dis. 2015;10(1):130. doi:10.1186/s13023-015-0350-6
   Web of Science ®Google Scholar
• Figueira Goncalves JM, Martinez Bugallo F, Diaz perez D, Martin Martinez MD, Garcia-Talavera I, Pitti Perez R. Clinical manifestations of the Mmalton alpha-1 antitrypsin deficiency variant. Pulmonology. 2017. doi:10.1016/j.rppnen.2017.11.004
   Web of Science ®Google Scholar
• Lomas DA, Elliott PR, Sidhar SK, et al. Alpha 1-antitrypsin mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem. 1995;270(28):16864–16870. doi:10.1074/jbc.270.28.16864
   PubMed Web of Science ®Google Scholar
• Callea F, Giovannoni I, Francalanci P, et al. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency. Orphanet J Rare Dis. 2018;13(1):79. doi:10.1186/s13023-018-0821-7
   PubMed Web of Science ®Google Scholar
• Miranda E, Perez J, Ekeowa UI, et al. A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency. Hepatology. 2010;52(3):1078–1088. doi:10.1002/hep.23760
   Web of Science ®Google Scholar
• Medicina D, Montani N, Fra AM, et al. Molecular characterization of the new defective P(brescia) alpha1-antitrypsin allele. Hum Mutat. 2009;30(8):E771–81. doi:10.1002/humu.21043
   Web of Science ®Google Scholar
• Fra AM, Gooptu B, Ferrarotti I, et al. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization. PLoS One. 2012;7(6):e38405. doi:10.1371/journal.pone.0038405
   Web of Science ®Google Scholar
• Poller W, Merklein F, Schneider-Rasp S, et al. Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Eur J Hum Genet. 1999;7(3):321–331. doi:10.1038/sj.ejhg.5200304
   Web of Science ®Google Scholar
• Owen MC, Brennan SO, Lewis JH, Carrell RW. Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med. 1983;309(12):694–698. doi:10.1056/NEJM198309223091203
   Web of Science ®Google Scholar
• Hua B, Fan L, Liang Y, Zhao Y, Tuddenham EGD. 1-antitrypsin Pittsburgh in a family with bleeding tendency. Haematologica. 2009;94(6):881–884. doi:10.3324/haematol.2008.004739
   Web of Science ®Google Scholar
• Cook L, Burdon JGW, Brenton S, et al. Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase. Pathology. 1996;28(3):242–247. doi:10.1080/00313029600169074
   Web of Science ®Google Scholar
• Okayama H, Brantly M, Holmes M, Crystal RG. Characterization of the molecular basis of the alpha 1-antitrypsin F allele. Am J Hum Genet. 1991;48(6):1154–1158.
   Web of Science ®Google Scholar
• Renoux C, Odou MF, Tosato G, et al. Description of 22 new alpha-1 antitrypsin genetic variants. Orphanet J Rare Dis. 2018;13(1):161. doi:10.1186/s13023-018-0897-0
   Web of Science ®Google Scholar
• Lee JH, Brantly M. Molecular mechanisms of alpha1-antitrypsin null alleles. Respir Med. 2000;94(Suppl C):S7–11. doi:10.1053/rmed.2000.0851
   Web of Science ®Google Scholar
• Hofker MH, Nukiwa T, van Paassen HM, et al. A Pro—-Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen. Hum Genet. 1989;81(3):264–268. doi:10.1007/BF00279001
   Web of Science ®Google Scholar
• Fregonese L, Stolk J, Frants RR, Veldhuisen B. Alpha-1 antitrypsin null mutations and severity of emphysema. Respir Med. 2008;102(6):876–884. doi:10.1016/j.rmed.2008.01.009
   PubMed Web of Science ®Google Scholar
• Seixas S, Mendonca C, Costa F, Rocha J. Alpha1-antitrypsin null alleles: evidence for the recurrence of the L353fsX376 mutation and a novel G–>A transition in position +1 of intron IC affecting normal mRNA splicing. Clin Genet. 2002;62(2):175–180. doi:10.1034/j.1399-0004.2002.620212.x
   PubMed Web of Science ®Google Scholar
• Lara B, Martinez MT, Blanco I, et al. Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. Respir Res. 2014;15:125. doi:10.1186/s12931-014-0125-y
   Web of Science ®Google Scholar
• Nguyen LS, Wilkinson MF, Gecz J. Nonsense-mediated mRNA decay: inter-individual variability and human disease. Neurosci Biobehav Rev. 2014;46(Pt 2):175–186. doi:10.1016/j.neubiorev.2013.10.016
   Web of Science ®Google Scholar
• Vaz Rodrigues L, Costa F, Marques P, Mendonca C, Rocha J, Seixas S. Severe alpha-1 antitrypsin deficiency caused by Q0(Ourem) allele: clinical features, haplotype characterization and history. Clin Genet. 2012;81(5):462–469. doi:10.1111/j.1399-0004.2011.01670.x
   PubMed Web of Science ®Google Scholar
• Bellemare J, Gaudreault N, Valette K, et al. The clinical utility of determining the allelic background of mutations causing alpha-1 antitrypsin deficiency: the case with the null variant Q0(Mattawa)/Q0(ourem). Chronic Obstr Pulm Dis. 2020. doi:10.15326/jcopdf.8.1.2020.0168
   Web of Science ®Google Scholar
• Hernández Pérez JM, Ramos Díaz R, Fumero García S, Pérez Pérez JA. Description of alpha-1-antitrypsin deficiency associated with PI*Q0ourém allele in La Palma Island (Spain) and a genotyping assay for detection. Arch Bronconeumol. 2015;51(1):e1–e3. doi:10.1016/j.arbr.2014.11.019
   Google Scholar
• Curiel D, Brantly M, Curiel E, Stier L, Crystal RG. Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin. J Clin Invest. 1989;83(4):1144–1152. doi:10.1172/JCI113994
   Web of Science ®Google Scholar
• Hildesheim J, Kinsley G, Bissell M, Pierce J, Brantly M. Genetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha 1-antitrypsin deficiency variant Pduarte. Hum Mutat. 1993;2(3):221–228. doi:10.1002/humu.1380020311
   Web of Science ®Google Scholar
• Liu X, Wu C, Li C, Boerwinkle E. dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Hum Mutat. 2016;37(3):235–241. doi:10.1002/humu.22932
   PubMed Web of Science ®Google Scholar
• Faber JP, Weidinger S, Olek K. Sequence data of the rare deficient alpha 1-antitrypsin variant PI Zaugsburg. Am J Hum Genet. 1990;46(6):1158–1162.
   Web of Science ®Google Scholar
• Malik R, Dau T, Gonik M, et al. Common coding variant in SERPINA1 increases the risk for large artery stroke. Proc Natl Acad Sci U S A. 2017;114(14):3613–3618. doi:10.1073/pnas.1616301114
   PubMed Web of Science ®Google Scholar
• Dickens JA, Lomas DA. Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther. 2011;5:391–405. doi:10.2147/DDDT.S14018
   PubMed Web of Science ®Google Scholar
• Ferrarotti I, Carroll TP, Ottaviani S, et al. Identification and characterisation of eight novel SERPINA1 Null mutations. Orphanet J Rare Dis. 2014;9(1):172. doi:10.1186/s13023-014-0172-y
   PubMed Web of Science ®Google Scholar
• Seixas S, Garcia O, Amorim A, Rocha J. A novel alpha-1-antitrypsin r281del variant found in a population sample from the Basque country. Hum Mutat. 2000;15(1):121–122. doi:10.1002/(SICI)1098-1004(200001)15:1<121::AID-HUMU37>3.0.CO;2-U
   Google Scholar
• Jardi R, Rodriguez F, Miravitlles M, et al. Identification and molecular characterization of the new alpha-1-antitrypsin deficient allele PI Y Barcelona (Asp256–>Val and Pro391–>His). Mutations in brief no. 174. online. Hum Mutat. 1998;12(3):213.
   Google Scholar
• Seixas S, Trovoada M, Santos M, Rocha J. A novel alpha-1-antitrypsin P362H variant found in a population sample from São Tomé e Príncipe (Gulf of Guinea, West Africa). Hum Mutat. 1999;13(5):414.
   Google Scholar
• Matamala N, Gomez-Mariano G, Perez JA, et al. New cis-acting variants in pi*s background produce null phenotypes causing alpha-1 antitrypsin deficiency. Am J Respir Cell Mol Biol. 2020;63(4):444–451. doi:10.1165/rcmb.2020-0021OC
   Web of Science ®Google Scholar
• Matamala N, Lara B, Gomez-Mariano G, et al. Characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency. Am J Respir Cell Mol Biol. 2018;58(6):706–716. doi:10.1165/rcmb.2017-0179OC
   Web of Science ®Google Scholar
• Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest. 1990;85(5):1343–1352. doi:10.1172/JCI114578
   Web of Science ®Google Scholar
• DeLano WL. The PyMOL molecular graphics system. DeLano Scientific; 2002. Available from: http://www.pymol.org. Accessed February 25, 2021.
   Google Scholar